Thermo Fisher Scientific (TMO)
EBITDA Growth
-11.61%
Quarterly · Period ending:
TMO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.61%period ending
Latest reported-11.61%period ending
TMO Quarterly EBITDA YoY % (35.02% → -11.61%)
Year-over-year change
High-resolution chart · PNG
TMO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 7.3449% | |
| -19.8007% | |
| 1.2695% | |
| 490.2072% | |
| -37.5113% | |
| -26.7007% | |
| -6.2653% | |
| -90.834% | |
| -33.1189% | |
| -27.2349% | |
| -39.7734% | |
| -22.8171% | |
| -6.7585% | |
| 48.374% | |
| 32.1862% | |
| 79.7251% | |
| 95.1344% | |
| 58.4541% | |
| 73.638% | |
| 18.1326% | |
| 14.1813% | |
| 7.6256% | |
| 20.0422% | |
| 38.3895% | |
| 45.8422% | |
| 34.8131% | |
| 28.4553% | |
| 40.5263% | |
| 18.4343% | |
| 82.1277% | |
| 0.545% | |
| 104.3011% | |
| 65% | |
| 38.2353% | |
| 321.8391% | |
| 104.3956% | |
| 163.7363% | |
| 82.7957% | |
| -5.4348% | |
| -34.5324% | |
| -32.5926% | |
| 40.9091% | |
| -1.0753% | |
| 98.5714% | |
| 117.7419% | |
| -95.6233% | |
| -93.2216% | |
| 102.1142% | |
| -95.0637% | |
| 24.2175% | |
| 32.9457% | |
| -11.2941% | |
| 15.1237% | |
| 27.1204% | |
| 10.7296% | |
| -28.8995% | |
| 28.0516% | |
| 19.8243% | |
| 19.0294% | |
| -20.5852% | |
| 35.0238% |